Meu SciELO
Serviços Personalizados
Journal
Artigo
Indicadores
Citado por SciELO
Acessos
Links relacionados
Citado por Google
Similares em SciELO
Similares em Google
Compartilhar
Revista de la Sociedad Española del Dolor
versão impressa ISSN 1134-8046
Resumo
ALONSO, A. e FRANCO, Mª L.. Diferences in the measurements of quality of lire trough Coop-Wonca cartoons in fibromyalgia patients in treatment with or without pregabaline. Rev. Soc. Esp. Dolor [online]. 2006, vol.13, n.1, pp.18-23. ISSN 1134-8046.
Objective: About the evolution of patients with Fibromyalgia it is interesting to know the results of measures assesing of the health-related quality of life.The interest annhace with the use of a new drug, pregabalin, the lastest generation anti-convulsivant, a ligand of a2-d subunit of calcium chanels. Helped by the COOP-WONCA charts ( reliable Spanish version of Nottingham Health Profile) our aim is determine if pregabalin improve the health-related quality of life in a group of Fibromyalgia affected patients. Methods: This trial compared the results of Coop-Wonca charts without pregabalin, with dosis of 300 and 600 mg/day pregabalin in a group of 16 patients with Fibromyalgia. All patients were continuated with their medications. Results: Pregabalin at 300 and 600 mg/day did not significantly improvement in the results of Coop/Wonca charts (p 0.05). Dizziness and weight gain were the most frequent adverse events. Conclusion: The scale of health-related quality of life Coop/Wonca did not result in improvement in our group of 16 patientes with Fibromyalgia when pregabalin was add to the treatment. Further study with a large group of patients is necessary to draw more conclusions on this point.
Palavras-chave : Health-related quality of life; Fibromyalgia; Pregabalin; Coop-Wonca charts.